ES2298244T5 - Método para la detección de los virus de la gripe A/B en saliva - Google Patents
Método para la detección de los virus de la gripe A/B en saliva Download PDFInfo
- Publication number
- ES2298244T5 ES2298244T5 ES01956475.6T ES01956475T ES2298244T5 ES 2298244 T5 ES2298244 T5 ES 2298244T5 ES 01956475 T ES01956475 T ES 01956475T ES 2298244 T5 ES2298244 T5 ES 2298244T5
- Authority
- ES
- Spain
- Prior art keywords
- influenza
- saliva
- detection
- virus
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003296 saliva Anatomy 0.000 title claims abstract description 85
- 238000001514 detection method Methods 0.000 title claims abstract description 74
- 208000037797 influenza A Diseases 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 25
- 241000700605 Viruses Species 0.000 title claims description 37
- 208000037798 influenza B Diseases 0.000 title claims description 32
- 239000000523 sample Substances 0.000 claims abstract description 58
- 238000012360 testing method Methods 0.000 claims abstract description 56
- 241000712431 Influenza A virus Species 0.000 claims abstract description 25
- 208000015181 infectious disease Diseases 0.000 claims abstract description 12
- 230000001900 immune effect Effects 0.000 claims description 23
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 13
- 102000039446 nucleic acids Human genes 0.000 claims description 13
- 150000007523 nucleic acids Chemical class 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000005070 sampling Methods 0.000 claims description 7
- 102000011931 Nucleoproteins Human genes 0.000 claims description 6
- 108010061100 Nucleoproteins Proteins 0.000 claims description 6
- 108090001074 Nucleocapsid Proteins Proteins 0.000 claims description 5
- 239000012139 lysis buffer Substances 0.000 claims description 5
- 238000003757 reverse transcription PCR Methods 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 11
- 241000713196 Influenza B virus Species 0.000 abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 5
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 description 35
- 239000000463 material Substances 0.000 description 25
- 210000003800 pharynx Anatomy 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 18
- 241000712461 unidentified influenza virus Species 0.000 description 18
- 230000003612 virological effect Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 7
- 230000009089 cytolysis Effects 0.000 description 7
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000003745 diagnosis Methods 0.000 description 6
- 230000000241 respiratory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 239000012149 elution buffer Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 4
- 102000005348 Neuraminidase Human genes 0.000 description 4
- 108010006232 Neuraminidase Proteins 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 4
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000013610 patient sample Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241001500351 Influenzavirus A Species 0.000 description 2
- 241000725643 Respiratory syncytial virus Species 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002911 sialidase inhibitor Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PCDWFBFHIIKIPM-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-2-sulfonic acid Chemical compound C1=CC=C2N(CC)C(S(O)(=O)=O)SC2=C1 PCDWFBFHIIKIPM-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001500350 Influenzavirus B Species 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 235000012364 Peperomia pellucida Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- -1 RNA Chemical class 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 241000868182 Thermus thermophilus HB8 Species 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
- 239000007998 bicine buffer Substances 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000009850 completed effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical group SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229940071125 manganese acetate Drugs 0.000 description 1
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000010908 plant waste Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000010340 saliva test Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000011120 smear test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10028837A DE10028837A1 (de) | 2000-06-15 | 2000-06-15 | Verfahren zum Nachweis von Influenza A/B-Viren |
| DE10028837 | 2000-06-15 | ||
| PCT/EP2001/006735 WO2001096595A2 (de) | 2000-06-15 | 2001-06-15 | Verfahren zum nachweis von influenza a/b-viren aus speichel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2298244T3 ES2298244T3 (es) | 2008-05-16 |
| ES2298244T5 true ES2298244T5 (es) | 2014-11-14 |
Family
ID=7645396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01956475.6T Expired - Lifetime ES2298244T5 (es) | 2000-06-15 | 2001-06-15 | Método para la detección de los virus de la gripe A/B en saliva |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6811971B2 (enExample) |
| EP (1) | EP1297187B2 (enExample) |
| JP (1) | JP2004503248A (enExample) |
| AT (1) | ATE385259T1 (enExample) |
| AU (1) | AU2001278452A1 (enExample) |
| CA (1) | CA2412121C (enExample) |
| DE (2) | DE10028837A1 (enExample) |
| ES (1) | ES2298244T5 (enExample) |
| WO (1) | WO2001096595A2 (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004028342A2 (en) * | 2002-09-25 | 2004-04-08 | Board Of Regents, The University Of Texas System | Endogenous granzyme b in human non-hematopoietic cells |
| AU2006244460B2 (en) * | 2005-05-06 | 2010-04-08 | Gen-Probe Incorporated | Compositions and assays to detect influenza virus A and B nucleic acids |
| WO2007098184A2 (en) * | 2006-02-21 | 2007-08-30 | Nanogen, Inc. | Methods and compositions for analyte detection |
| US20080208486A1 (en) * | 2006-03-23 | 2008-08-28 | Jari Natunen | Integrated System, Device and Use Thereof |
| US20070238095A1 (en) * | 2006-04-11 | 2007-10-11 | Mayo Foundation For Medical Education And Research , A Minnesota Corporation | Detection of Influenza A Virus |
| US20070238093A1 (en) * | 2006-04-11 | 2007-10-11 | Espy Mark J | Detection of influenza A virus |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| FI20060946A0 (fi) * | 2006-10-26 | 2006-10-26 | Glykos Finland Oy | Influenssaviruksen nukleiinihappoja ja peptidejä |
| WO2008057605A2 (en) * | 2006-11-10 | 2008-05-15 | Quidel Corporation | Nuclear protein extraction medium and method of use |
| CA2684213A1 (en) | 2007-04-12 | 2008-10-23 | Regents Of The University Of Minnesota | Ischemia/reperfusion protection compositions and methods of using |
| EP2174957B1 (en) | 2007-06-15 | 2016-03-16 | Xiamen University | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| US9689031B2 (en) | 2007-07-14 | 2017-06-27 | Ionian Technologies, Inc. | Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| EP3058954B1 (en) | 2007-08-27 | 2017-03-01 | Longhorn Vaccines and Diagnostics, LLC | Immunogenic compositions and methods |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| ES2552858T3 (es) * | 2007-10-01 | 2015-12-02 | Longhorn Vaccines And Diagnostics, Llc | Recogida de muestras biológicas y sistema de transporte y métodos de uso |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| US20110046001A1 (en) * | 2007-11-20 | 2011-02-24 | Autogenomics, Inc. | Multiplex Assay for Respiratory Viruses |
| US8354230B2 (en) | 2007-12-21 | 2013-01-15 | Quest Diagnostics Investments Inc. | Multiplex detection assay for influenza and RSV viruses |
| WO2009142742A1 (en) * | 2008-05-20 | 2009-11-26 | Cantimer, Inc. | Methods, systems and devices for analyzing a biological fluid sample following ion exchange |
| US20110045458A1 (en) * | 2009-08-20 | 2011-02-24 | Mayo Foundation For Medical Education And Research | Detection of Enterovirus |
| KR101919330B1 (ko) * | 2011-06-16 | 2018-11-19 | 후지필름 가부시키가이샤 | 고감도의 면역크로마토그래프 방법 및 면역크로마토그래프용 키트 |
| EP3494989B1 (en) | 2012-01-26 | 2025-07-16 | Longhorn Vaccines and Diagnostics, LLC | Composite antigenic sequences and vaccines |
| CA2985652C (en) | 2015-05-14 | 2020-03-10 | Gerald W. FISHER | Rapid methods for the extraction of nucleic acids from biological samples |
| US10307398B2 (en) | 2016-09-20 | 2019-06-04 | Regents Of The University Of Minnesota | Resuscitation composition and methods of making and using |
| GB201703383D0 (en) | 2017-03-02 | 2017-04-19 | Gargle Tech Ltd | Testing for particulates |
| EP4205851A3 (en) | 2018-09-05 | 2023-10-04 | Hero Scientific Ltd | Testing for particulates |
| WO2020095584A1 (ja) * | 2018-11-08 | 2020-05-14 | パナソニックＩｐマネジメント株式会社 | 検出システム及び情報表示システム |
| WO2020116012A1 (ja) | 2018-12-04 | 2020-06-11 | 株式会社村田製作所 | ウイルス検出システム、ウイルス検出方法、及びウイルス検出プログラム |
| US11053531B2 (en) | 2019-05-31 | 2021-07-06 | Linda Marie Petter | Tester paper and methods of use thereof for detecting a bacterial infection |
| WO2021181339A1 (en) | 2020-03-11 | 2021-09-16 | Hero Scientific Ltd. | Testing devices |
| CA3202405A1 (en) | 2021-01-06 | 2022-07-14 | Zvi Feldman | Filtration sampling devices |
| US20240302370A1 (en) * | 2021-02-12 | 2024-09-12 | Siemens Healthcare Diagnostics Inc. | Sample lysis reagent compositions and methods of production and use thereof |
| US20240410910A1 (en) * | 2021-07-22 | 2024-12-12 | Assaya Llc | Machine testing quality verification |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2104683C (en) | 1990-12-31 | 2004-06-29 | Avraham Liav | Method for visually detecting the presence of a virus in a clinical specimen |
| FR2708348B1 (fr) | 1993-07-28 | 1995-10-06 | Stago Diagnostica | Procédé de dosage d'une substance immunologique au moyen de particules de latex magnétiques et de particules non-magnétiques. |
| US5714341A (en) | 1994-03-30 | 1998-02-03 | Epitope, Inc. | Saliva assay method and device |
| US6015664A (en) | 1995-11-03 | 2000-01-18 | Mcw Research Foundation | Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B |
| EP1010981A1 (de) | 1998-12-18 | 2000-06-21 | Diagor GmbH | Konjugate zum Nachweis von Viren und deren Verwendung |
-
2000
- 2000-06-15 DE DE10028837A patent/DE10028837A1/de not_active Ceased
-
2001
- 2001-06-15 AU AU2001278452A patent/AU2001278452A1/en not_active Abandoned
- 2001-06-15 EP EP01956475.6A patent/EP1297187B2/de not_active Expired - Lifetime
- 2001-06-15 ES ES01956475.6T patent/ES2298244T5/es not_active Expired - Lifetime
- 2001-06-15 AT AT01956475T patent/ATE385259T1/de active
- 2001-06-15 CA CA002412121A patent/CA2412121C/en not_active Expired - Fee Related
- 2001-06-15 JP JP2002510708A patent/JP2004503248A/ja active Pending
- 2001-06-15 US US10/311,523 patent/US6811971B2/en not_active Expired - Lifetime
- 2001-06-15 DE DE50113548T patent/DE50113548D1/de not_active Expired - Lifetime
- 2001-06-15 WO PCT/EP2001/006735 patent/WO2001096595A2/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE50113548D1 (de) | 2008-03-20 |
| DE10028837A1 (de) | 2001-12-20 |
| EP1297187B1 (de) | 2008-01-30 |
| US6811971B2 (en) | 2004-11-02 |
| ES2298244T3 (es) | 2008-05-16 |
| US20030143530A1 (en) | 2003-07-31 |
| WO2001096595A2 (de) | 2001-12-20 |
| EP1297187B2 (de) | 2014-08-13 |
| AU2001278452A1 (en) | 2001-12-24 |
| ATE385259T1 (de) | 2008-02-15 |
| JP2004503248A (ja) | 2004-02-05 |
| WO2001096595A3 (de) | 2002-05-23 |
| CA2412121A1 (en) | 2002-12-09 |
| CA2412121C (en) | 2009-09-01 |
| EP1297187A2 (de) | 2003-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2298244T5 (es) | Método para la detección de los virus de la gripe A/B en saliva | |
| ES2969574T3 (es) | Composición, kit y método para detectar y tipificar virus que provocan una infección del tracto respiratorio y aplicación de composición, kit y método | |
| Rota et al. | Detection of measles virus RNA in urine specimens from vaccine recipients | |
| TWI631217B (zh) | 生物體識別產品及方法 | |
| Nishi et al. | Polymerase chain reaction for the detection of the varicella-zoster genome in ocular samples from patients with acute retinal necrosis | |
| Afzal et al. | Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK | |
| CN102337351B (zh) | 一种流感病毒分型检测试剂盒 | |
| CN115754277B (zh) | 一种猴痘病毒抗原检测试剂盒及制备方法 | |
| Mérens et al. | Ebola virus disease: Biological and diagnostic evolution from 2014 to 2017 | |
| Purohit et al. | Sampling and analytical techniques for COVID-19 | |
| US20240094205A1 (en) | Immunological test for the detection of viral infections | |
| CN104212914B (zh) | 埃博拉五重荧光pcr快速超敏检测试剂盒及其应用 | |
| CN105769212A (zh) | 一种避孕套 | |
| CN102618665B (zh) | 一种荧光pcr检测单纯疱疹病毒i型的试剂盒 | |
| CN115803455A (zh) | 简易鼻腔粘膜表面附着粘液的采集方法及用于检测该样本中的待检测物的检查试剂盒 | |
| CN111172320A (zh) | 呼吸道合胞病毒f基因的检测引物、试剂盒及方法 | |
| Subramaniam et al. | Diagnosis of Foot and Mouth Disease | |
| Kanlayanadonkit | Evaluation of the Solana Flu A and B assay for rapid identification and differentiation of Influenza A Virus and Influenza B virus | |
| Kaore et al. | Laboratory diagnosis of novel H1N1 virus | |
| Kumar et al. | Recent advances and strategies in diagnostic tools, therapeutic and prophylactic measures | |
| Romanova et al. | LABORATORY METHODS FOR DETERMINING NEW COVID-19 INFECTION | |
| CN106048098A (zh) | 多重核酸体外诊断疱疹病毒的试剂盒及其应用 | |
| Aldalaen | INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES | |
| Budama‐Kilinc et al. | Influenza diagnosis with a specific emphasis on the M2e antigen as a diagnostic tool | |
| WO2022141394A1 (zh) | 一种用于检测新型冠状病毒抗体的无创取样检测试剂盒及其检测方法 |